Culturing Biology: Cell Lines for the Second Millennium
Culturing Biology: Cell Lines for the Second Millennium
复制标题
培养生物学：第二个千年的细胞系
DOI：
10.1177/136345930100500304
复制
发表时间：
2001
期刊：
影响因子：
--
通讯作者：
S. Franklin
中科院分区：
文献类型：
--
作者：
S. Franklin
公众对创新的生物医学保健技术，如人的治疗性克隆的关注，已成为迅速增加的社会科学文献的主题。这类文献中的一个突出论点是，在一些人所谓的“生物控制时代”的背景下，“社会”本身正在经历根本性的转变。本文询问的问题，社会关系是如何被改造，或搬迁，在细胞系本身通过检查最近的合并之间的杰龙公司和罗斯林生物。争论某些社会关注正在建立在细胞系中，“生物控制”的问题被重新定义为社会关系之一。
Public concerns about innovative biomedical health technologies, such as human therapeutic cloning, have been the subject of a rapidly expanding social scientific literature. A prominent argument within much of this literature is that ‘the social’ is itself undergoing fundamental transformation in the context of what some have called ‘the age of biological control’. This article interrogates the question of how social relationality is being transformed, or relocated, within the cell line itself by examining the recent merger between Geron Corporation and Roslin Biomed. Arguing certain social concerns are being built in to the cell line, the question of ‘biological control’ is refigured as one of social relationality.